Weight gain and longterm complications with atypical antipsychotics.
作者信息
Farver D
出版信息
S D J Med. 2001 Jan;54(1):11-2.
PMID:11211419
Abstract
摘要
相似文献
1
Weight gain and longterm complications with atypical antipsychotics.
S D J Med. 2001 Jan;54(1):11-2.
2
When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
J Am Diet Assoc. 2010 Jul;110(7):992-1001. doi: 10.1016/j.jada.2010.05.015.
3
Weight Gain Risk Factor assessment checklist: overview and recommendation for use.
Neuro Endocrinol Lett. 2011;32(2):199-205.
4
Psychiatric medication-induced obesity: treatment options.
Obes Rev. 2004 Nov;5(4):233-8. doi: 10.1111/j.1467-789X.2004.00149.x.
5
Antipsychotic-associated weight gain and clinical outcome parameters.
J Clin Psychiatry. 2001;62 Suppl 7:11-21.
6
[Atypical antipsychotic-induced weight gain].
Psychiatr Pol. 2006 Sep-Oct;40(5):995-1007.
7
The Management of Obesity in People with Severe Mental Illness: An Unresolved Conundrum.
Psychother Psychosom. 2019;88(6):327-332. doi: 10.1159/000503835. Epub 2019 Oct 4.
8
Atypical antipsychotics and weight gain.
Postgrad Med. 2003 Dec;114(6 Suppl Managing Metabolic):46-58. doi: 10.3810/pgm.12.2003.suppl31.180.
9
Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
J Clin Psychiatry. 2004;65 Suppl 6:20-9.
10
Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?
J Clin Psychiatry. 2005 Oct;66(10):1331-2. doi: 10.4088/jcp.v66n1018.
引用本文的文献
1
Olanzapine-induced cardiomyopathy: A mimicker of obesity cardiomyopathy?
Clin Cardiol. 2024 May;47(5):e24278. doi: 10.1002/clc.24278.
2
Weight gain with olanzapine: Drug, gender or age?
Indian J Psychiatry. 2006 Jan;48(1):39-42. doi: 10.4103/0019-5545.31617.
Zotero 插件